The Clinical Efficacy of Switching Therapy Between Biological Agents and JAK Inhibitors in the Patients with Rheumatoid Arthritis

被引:0
|
作者
Choshi, Tomokazu [1 ]
Mamoto, Kenji [1 ]
Yamada, Yutaro [1 ]
Okano, Tadashi [1 ]
Anno, Shohei [2 ]
Orita, Kazuki [2 ]
Iida, Takahiro [3 ]
Tada, Masahiro [4 ]
Inui, Kentaro [5 ]
Koike, Tatsuya [6 ]
Nakamura, Hiroaki [1 ]
机构
[1] Osaka Metropolitan Univ, Osaka, Japan
[2] Yodogawa Christians Hosp, Osaka, Japan
[3] Koryokai Hosp, Osaka, Japan
[4] Osaka City Gen Hosp, Osaka, Japan
[5] Saiseikai Nakatsu Hosp, Osaka, Japan
[6] Shirahama Fdn Hlth & Welf, Search Inst Bone & Arthrit Dis SINBAD, Shirahama, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0426
引用
收藏
页码:826 / 827
页数:2
相关论文
共 50 条
  • [1] Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis
    Taylor, Peter C.
    RHEUMATOLOGY, 2019, 58 : 17 - 26
  • [2] Efficacy and safety of switching Jak inhibitors in rheumatoid arthritis: an observational study
    Retuerto, M.
    Trujillo, E.
    Valero, C.
    Fernandez-Espartero, C.
    Soleto, C. Y.
    Garcia-Valle, A.
    Aurrecoechea, E.
    Garijo, M.
    Lopez, A.
    Loricera, J.
    Pablos, J. L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (03) : 453 - 455
  • [3] JAK Inhibitors in Rheumatoid Arthritis: Immunomodulatory Properties and Clinical Efficacy
    Kielbowski, Kajetan
    Plewa, Paulina
    Bratborska, Aleksandra Wiktoria
    Bakinowska, Estera
    Pawlik, Andrzej
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)
  • [4] SURVIVAL ANALYSIS OF BIOLOGICAL DMARDS AND JAK INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS REQUIRING SWITCHING OF TREATMENT
    Bobkova, A. O.
    Glukhova, S. I.
    Karateev, A. E.
    Potapova, A. S.
    Lila, A. M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S149 - S150
  • [5] EFFICACY OF JAK INHIBITORS IN REFRACTORY RHEUMATOID ARTHRITIS
    Kamiya, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1468 - 1468
  • [6] Real Life Severe Infections in Patients with Rheumatoid Arthritis on Treatment with Biological Therapy and JAK Inhibitors
    Vega-Alvarez, Lucia
    Calvo-Zorrilla, Itziar
    Ibarguengoitia-Barrena, Oihane
    Blanco-Madrigal, Juan M.
    Montero-Seisdedos, David
    Garcia-Gomez, Carmen L.
    Esther Ruiz-Lucea, Maria
    Inchaurbe-Pellejero, Ana R.
    Torre-Salaberri, Ignacio
    Perez-Velasquez, Clara E.
    Fernandez-Berrizbeitia, Olaia
    Cuende-Quintana, Eduardo
    Gorostiza-Hormaetxe, Inigo R.
    Luz Garcia-Vivar, Maria
    Galindez-Agirregoikoa, Eva
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [7] Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry
    Miyazaki, Yusuke
    Nakayamada, Shingo
    Tanaka, Hiroaki
    Hanami, Kentaro
    Fukuyo, Shunsuke
    Kubo, Satoshi
    Yamaguchi, Ayako
    Miyagawa, Ippei
    Satoh-Kanda, Yurie
    Todoroki, Yasuyuki
    Inoue, Yoshino
    Ueno, Masanobu
    Tanaka, Yoshiya
    RMD OPEN, 2025, 11 (01):
  • [8] EVALUATION OF STRUCTURE AND CAUSES FOR SWITCHING BDMARDS AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Bobkova, A. O.
    Potapova, A. S.
    Sholkina, P. A.
    Karateev, A. E.
    Polishchuk, E. Y. U.
    Lila, A. M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S149 - S149
  • [9] Efficacy and Safety of JAK Inhibitors in Difficult to Treat Rheumatoid Arthritis in Clinical Practice
    Al Tabaa, Omar
    Hecquet, Sophie
    Thomas, Marion
    Carves, Sandrine
    Combier, Alice
    Miceli, Corinne
    Fogel, Olivier
    Molto, Anna
    Allanore, Yannick
    Avouac, Jerome
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2637 - 2639
  • [10] CLINICAL EFFICACY OF TNF INHIBITORS AND ABATACEPT IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS SWITCHING FROM TOCILIZUMAB
    Hirabara, S.
    Kojima, T.
    Takahashi, N.
    Yabe, Y.
    Kaneko, A.
    Kida, D.
    Hirano, Y.
    Ishiguro, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1057 - 1058